UHRF1 and neoplasm: By investigating the role of epigenetic regulator UHRF1 and its mechanism in the methylation of tumour suppressor genes in malignant T cells, following intervention with azacitidine and decitabine, we assessed the effectiveness of demethylating therapy for T‐LBL.